Literature DB >> 34141151

Promotion effects of DEHP on hepatocellular carcinoma models: up-regulation of PD-L1 by activating the JAK2/STAT3 pathway.

Qiang Xu1, Song Huang1, Zi-Ming Xu2, Ke Ji1, Xiang Zhang3, Wei-Ping Xu3, Wei Wei1.   

Abstract

Di(2-ethylhexyl) phthalate (DEHP), as an endocrine disruptor, is often used as a plasticizer in various polyvinyl chloride plastic products and medical consumables. Epidemiological studies have shown that long-term large intake of DEHP may be a risk factor for liver dysfunction. Long-term exposure to DEHP is associated with liver disease and aggravates the progression of chronic liver injury. However, the effects of DEHP on hepatocellular carcinoma (HCC) are rarely studied. In this study, we sought to determine the effects of DEHP on HCC induced by carbon tetrachloride combined with diethylnitrosamine, and further study its molecular mechanism. It was found that DEHP exposure significantly promotes tumor immune escape and activates signaling pathways involved in related protein expression of tumor immune escape, including PD-L1, JAK2, and STAT3. In addition, the trends observed in the HepG2 cells assay are consistent with vivo conditions. In summary, DEHP may play a tumor-promoting role in HCC mice and IFN-γ stimulated HepG2 cells, which may be related to the JAK2/STAT3 signaling pathway.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  DEHP; JAK2; PD-L1; STAT3; hepatocellular carcinoma (HCC); tumor immune escape

Year:  2021        PMID: 34141151      PMCID: PMC8201567          DOI: 10.1093/toxres/tfab018

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  41 in total

1.  Investigation of the amount of transdermal exposure of newborn babies to phthalates in paper diapers and certification of the safety of paper diapers.

Authors:  Satoko Ishii; Ritsuko Katagiri; Yasushi Minobe; Isamu Kuribara; Takeharu Wada; Mitsuhiro Wada; Shigeo Imai
Journal:  Regul Toxicol Pharmacol       Date:  2015-06-27       Impact factor: 3.271

2.  Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells.

Authors:  Mengyun Ke; Zhenhai Zhang; Biyi Xu; Shidi Zhao; Yiming Ding; Xiaoning Wu; Rongqian Wu; Yi Lv; Jian Dong
Journal:  Int Immunopharmacol       Date:  2019-08-19       Impact factor: 4.932

3.  Di(2-ethylhexyl) phthalate induced hepatotoxicity in quail (Coturnix japonica) via modulating the mitochondrial unfolded protein response and NRF2 mediated antioxidant defense.

Authors:  Qi Zhang; Yi Zhao; Milton Talukder; Yu Han; Cong Zhang; Xue-Nan Li; Jin-Long Li
Journal:  Sci Total Environ       Date:  2018-09-17       Impact factor: 7.963

4.  Quantification of bis(2-ethylhexyl) phthalate released by medical devices during respiratory assistance and estimation of patient exposure.

Authors:  Yassine Bouattour; Mathieu Wasiak; Lise Bernard; Jérémy Pinguet; Damien Richard; Mégane Le Rouzo-Grèves; Imen Dhifallah; Céline Lambert; Bruno Pereira; Philip Chennell; Valérie Sautou
Journal:  Chemosphere       Date:  2020-05-07       Impact factor: 7.086

5.  IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.

Authors:  Wenjie Zhang; Yang Liu; Zhongyi Yan; Hui Yang; Wei Sun; Yongliang Yao; Yun Chen; Runqiu Jiang
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

6.  Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.

Authors:  Jesus M Banales; Mercedes Iñarrairaegui; Ander Arbelaiz; Piotr Milkiewicz; Jordi Muntané; Luis Muñoz-Bellvis; Adelaida La Casta; Luis M Gonzalez; Enara Arretxe; Cristina Alonso; Ibon Martínez-Arranz; Ainhoa Lapitz; Alvaro Santos-Laso; Matias A Avila; Maria L Martínez-Chantar; Luis Bujanda; Jose J G Marin; Bruno Sangro; Rocio I R Macias
Journal:  Hepatology       Date:  2019-02-14       Impact factor: 17.425

7.  DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.

Authors:  Ssu-Chuan Lai; Yu-Ting Su; Ching-Chi Chi; Yung-Che Kuo; Kam-Fai Lee; Yu-Chih Wu; Pei-Chi Lan; Muh-Hwa Yang; Te-Sheng Chang; Yen-Hua Huang
Journal:  J Exp Clin Cancer Res       Date:  2019-11-26

8.  Increased both PD-L1 and PD-L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis.

Authors:  Hidetaka Yasuoka; Akira Asai; Hideko Ohama; Yusuke Tsuchimoto; Shinya Fukunishi; Kazuhide Higuchi
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

Review 9.  Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.

Authors:  Go J Yoshida
Journal:  J Exp Clin Cancer Res       Date:  2020-06-16

10.  SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway.

Authors:  Mo Chen; Jia Zeng; Shuyi Chen; Jiajia Li; Huijie Wu; Xuhui Dong; Yuan Lei; Xiuling Zhi; Liangqing Yao
Journal:  Aging (Albany NY)       Date:  2020-06-08       Impact factor: 5.682

View more
  1 in total

1.  MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.

Authors:  Tong-Tong Li; Jie Mou; Yao-Jie Pan; Fu-Chun Huo; Wen-Qi Du; Jia Liang; Yang Wang; Lan-Sheng Zhang; Dong-Sheng Pei
Journal:  J Biomed Sci       Date:  2021-08-02       Impact factor: 8.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.